Speech-Language Pathologists in Lockport, IL Accepting Medicare

23 Speech-Language Pathologists found. Showing 1 - 20

Mrs. Sara Kristen Sutter, MS, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16736 S Parker Ridge Dr, Lockport, IL 60441 Phone: 630-605-2284

Emma Lagger Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 16626 W Springview Dr, Lockport, IL 60441 Phone: 815-735-3948

Mrs. Cynthia Trombetta Gleason, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1219 Keywest Dr, Lockport, IL 60441 Phone: 815-838-6744

Lmg Therapy, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16330 Cagwin Dr, Lockport, IL 60441 Phone: 765-491-2778    Fax: 815-524-3194

Prof. Judith Lynn Barker Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 565 E 7th St, Lockport, IL 60441 Phone: 815-838-0542

Miss Ophelia Rose Romeo, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 717 Cove Ave, Lockport, IL 60441 Phone: 708-263-8850

Twin Talkers S.c. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17008 Creighton Dr, Lockport, IL 60441 Phone: 815-823-4357    Fax: 815-600-8244

Dianna Celeste Skoczek, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 808 Adams St, Lockport, IL 60441 Phone: 815-838-0737

Mrs. Isabella Marie Bigos Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1343 East 7th Street, Lockport, IL 60441 Phone: 815-838-8080

Mrs. Shawnae Rimsnider, MHS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1900 S Farrell Rd, Lockport, IL 60441 Phone: 708-642-2299

Ashley Foster Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15451 S Scott Dr, Lockport, IL 60441 Phone: 708-945-8559

Ms. Monica Patla, MHS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1333 E 7th St, Lockport, IL 60441 Phone: 815-588-8140

Kathleen Joan Truse, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 514 Macgregor Rd, Lockport, IL 60441 Phone: 815-838-7858

Valerie Lyn Hogan, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1333 E 7th St, Lockport, IL 60441 Phone: 815-588-8143

Swanberg Pediatric Therapy P.c. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15118 W Austin Dr, Lockport, IL 60441 Phone: 630-730-9309    Fax: 779-205-6478

Mrs. Alexis Segovich, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17603 Alta Ct, Lockport, IL 60441 Phone: 815-834-1253

Sara E. Parsons, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17920 S Beechwood Ct, Lockport, IL 60441 Phone: 708-702-6222

Carrie Goodnight Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14631 Aston Way, Lockport, IL 60441 Phone: 708-261-4303

Erica Elizabeth Zakarauskas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16408 Newcastle Way, Lockport, IL 60441 Phone: 773-870-5346

Danielle Griffiths Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 710 N State St, Lockport, IL 60441 Phone: 815-838-8020

News Archive

Removing cost burden increases use of coronary artery calcium screening

A study out of University Hospitals found that removing the cost barrier for coronary artery calcium (CAC) screening resulted in an immediate increase in utilization of the test.

New strategies for managing foams and plastics containing harmful flame retardants

Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.

Ipsen announces results of phase III study of somatuline in patients with neuroendocrine tumors

Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the detailed results of phase III CLARINET study assessing the effect of Somatuline® Autogel® 120 mg in patients with gastrointestinal and pancreatic neuroendocrine tumors ("GEP-NETs")1 will be disclosed for the first time on September 28, 2013 at the European Cancer Congress 2013 (Sept. 27 - Oct. 1, 2013) in Amsterdam.

Alpha-synuclein protein involved in Parkinson's disease pathology does not behave like a 'prion'

In Parkinson's disease, the protein "alpha-synuclein" aggregates within neurons of patients and appears to propagate across interconnected areas of the brain. How this happens remains largely unknown.

Magnetic nanoparticles can 'heat up' tumor cells

Unfortunately, cancer isn't simply a single disease, and some types, like pancreas, brain or liver tumors, are still difficult to treat with chemotherapy, radiation therapy or surgery, leading to low survival rates for patients.

Read more Medical News

› Verified 1 days ago

• 1(current)
• 2